LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG
UNII 2C6YGZ385D
Substance Identification & Data
This profile provides standardized clinical and technical data for Linagliptin Hydroxyethylphthalimide Analog, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2C6YGZ385D.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2074688-80-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C35H37N9O5 ZFNQEMCRVBLZQE-HSZRJFAPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Linagliptin Hydroxyethylphthalimide Analog. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.